These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19088846)

  • 1. Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage.
    Krejci P; Salazar L; Kashiwada TA; Chlebova K; Salasova A; Thompson LM; Bryja V; Kozubik A; Wilcox WR
    PLoS One; 2008; 3(12):e3961. PubMed ID: 19088846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia.
    Matsushita M; Kitoh H; Ohkawara B; Mishima K; Kaneko H; Ito M; Masuda A; Ishiguro N; Ohno K
    PLoS One; 2013; 8(12):e81569. PubMed ID: 24324705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations.
    Ronchetti D; Greco A; Compasso S; Colombo G; Dell'Era P; Otsuki T; Lombardi L; Neri A
    Oncogene; 2001 Jun; 20(27):3553-62. PubMed ID: 11429702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.
    Foldynova-Trantirkova S; Wilcox WR; Krejci P
    Hum Mutat; 2012 Jan; 33(1):29-41. PubMed ID: 22045636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLCgamma-activated STAT1.
    Harada D; Yamanaka Y; Ueda K; Nishimura R; Morishima T; Seino Y; Tanaka H
    Bone; 2007 Aug; 41(2):273-81. PubMed ID: 17561467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes.
    Krejci P; Salazar L; Goodridge HS; Kashiwada TA; Schibler MJ; Jelinkova P; Thompson LM; Wilcox WR
    J Cell Sci; 2008 Feb; 121(Pt 3):272-81. PubMed ID: 18198189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF449 is a novel inhibitor of fibroblast growth factor receptor 3 (FGFR3) signaling active in chondrocytes and multiple myeloma cells.
    Krejci P; Murakami S; Prochazkova J; Trantirek L; Chlebova K; Ouyang Z; Aklian A; Smutny J; Bryja V; Kozubik A; Wilcox WR
    J Biol Chem; 2010 Jul; 285(27):20644-53. PubMed ID: 20439987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation.
    Hart KC; Robertson SC; Donoghue DJ
    Mol Biol Cell; 2001 Apr; 12(4):931-42. PubMed ID: 11294897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paradox of FGFR3 signaling in skeletal dysplasia: why chondrocytes growth arrest while other cells over proliferate.
    Krejci P
    Mutat Res Rev Mutat Res; 2014; 759():40-8. PubMed ID: 24295726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of fibroblast growth factor receptor-3 (FGFR3), signal transducer and activator of transcription-1, and cyclin-dependent kinase inhibitor p21 during endochondral ossification: differential role of FGFR3 in skeletal development and fracture repair.
    Nakajima A; Shimizu S; Moriya H; Yamazaki M
    Endocrinology; 2003 Oct; 144(10):4659-68. PubMed ID: 12960068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias.
    Legeai-Mallet L; Benoist-Lasselin C; Munnich A; Bonaventure J
    Bone; 2004 Jan; 34(1):26-36. PubMed ID: 14751560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum.
    Lievens PM; Liboi E
    J Biol Chem; 2003 May; 278(19):17344-9. PubMed ID: 12624096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors.
    Li C; Chen L; Iwata T; Kitagawa M; Fu XY; Deng CX
    Hum Mol Genet; 1999 Jan; 8(1):35-44. PubMed ID: 9887329
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Sun X; Zhang R; Chen H; Du X; Chen S; Huang J; Liu M; Xu M; Luo F; Jin M; Su N; Qi H; Yang J; Tan Q; Zhang D; Ni Z; Liang S; Zhang B; Chen D; Zhang X; Luo L; Chen L; Xie Y
    Theranostics; 2020; 10(16):7111-7130. PubMed ID: 32641982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant FGFR3 associated with SADDAN disease causes cytoskeleton disorganization through PLCγ1/Src-mediated paxillin hyperphosphorylation.
    Montone R; Romanelli MG; Baruzzi A; Ferrarini F; Liboi E; Lievens PM
    Int J Biochem Cell Biol; 2018 Feb; 95():17-26. PubMed ID: 29242050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib therapeutic effect is associated with expression and mutation of FGFR3 in human lymphoma cells.
    Zheng W; Guan M; Zhu L; Cai Z; Chung V; Huang H; Yen Y
    Anticancer Res; 2010 Jun; 30(6):1921-30. PubMed ID: 20651335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The localization of FGFR3 mutations causing thanatophoric dysplasia type I differentially affects phosphorylation, processing and ubiquitylation of the receptor.
    Bonaventure J; Horne WC; Baron R
    FEBS J; 2007 Jun; 274(12):3078-93. PubMed ID: 17509076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of FGFR3 signaling at the cell membrane via total internal reflection fluorescence microscopy to compare the activation of FGFR3 mutants.
    Hartl I; Brumovska V; Striedner Y; Yasari A; Schütz GJ; Sevcsik E; Tiemann-Boege I
    J Biol Chem; 2023 Feb; 299(2):102832. PubMed ID: 36581204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K644E/M FGFR3 mutants activate Erk1/2 from the endoplasmic reticulum through FRS2 alpha and PLC gamma-independent pathways.
    Lievens PM; Roncador A; Liboi E
    J Mol Biol; 2006 Mar; 357(3):783-92. PubMed ID: 16476447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse models orthologous to FGFR3-related skeletal dysplasias.
    Brodie SG; Deng CX
    Pediatr Pathol Mol Med; 2003; 22(1):87-103. PubMed ID: 12687892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.